All Cases

Pre-commercialization and Launch Strategy

Developed a launch excellence plan, based on local market inputs for a global pharmaceutical company

Developed a comprehensive understanding of referral flows for a Cell Therapy in development for Type 1 Diabetes to inform strategic commercial engagement planning at a mid-sized pharmaceutical company

Defined the key requirements for novel GTx entry and regional access to inform regional access strategies and planned activities and further organizational alignment initiatives

Developed drivers and potential barriers of Hematologist GTx adoption to understand the impacts on patient adoption and inform strategic commercialization planning for a mid-sized biotech

Reconstructed launch experience to inform early commercial planning at a large pharmaceutical company developing a GTx

Characterized Hemophilia GTx Infusion center networks and developed processes to track and validate center readiness, informing commercial strategy and planning at a large pharmaceutical company

Developed a comprehensive understanding of the DMD GTx infrastructure of care to wholistically inform commercial planning for a large pharmaceutical company

Built a geographic view of the treatment landscape for familial hypercholesterolemia to understand treatment adoption and inform our biotech client’s action plan and resourcing requirements

Identification of emerging market launch scenarios with highest success probability for a large pharmaceutical company 

Investigated adoption pain points for an appetite suppressant and their impact on adoption / adherence to underpin financial modeling and inform strategic commercialization investment at a small biotech